Full Text | PDF

Share on tweeters Share on facebook Share on linkedin Share on googleplus

Theranostics 2018; 8(20):5660-5661. doi:10.7150/thno.31152 This issue Cite

Erratum

In-Tether Chiral Center Induced Helical Peptide Modulators Target p53-MDM2/MDMX and Inhibit Tumor Growth in Stem-Like Cancer Cell: Erratum

Kuan Hu1*, Feng Yin1*, Mengyin Yu1, Chengjie Sun1, Jingxu Li1, Yujie Liang1, Wenjun Li1, Mingsheng Xie1, Yuanzhi Lao3, Wei Liang2✉, Zi-gang Li1✉

1. School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School, Shenzhen, 518055, China
2. Department of Radiation Oncology, the First Affiliated Hospital, Anhui Medical University, Hefei, 230022, China
3. School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China
* These authors contributed equally to this work.

✉ Corresponding authors: Zi-gang Li, email: lizgedu.cn Wei Liang, email: williamleungcom

Citation:
Hu K, Yin F, Yu M, Sun C, Li J, Liang Y, Li W, Xie M, Lao Y, Liang W, Li Zg. In-Tether Chiral Center Induced Helical Peptide Modulators Target p53-MDM2/MDMX and Inhibit Tumor Growth in Stem-Like Cancer Cell: Erratum. Theranostics 2018; 8(20):5660-5661. doi:10.7150/thno.31152. https://www.thno.org/v08p5660.htm
Other styles

File import instruction

Corrected-article in Theranostics, Volume 7, 4566

Citation styles

APA
Hu, K., Yin, F., Yu, M., Sun, C., Li, J., Liang, Y., Li, W., Xie, M., Lao, Y., Liang, W., Li, Z.g. (2018). In-Tether Chiral Center Induced Helical Peptide Modulators Target p53-MDM2/MDMX and Inhibit Tumor Growth in Stem-Like Cancer Cell: Erratum. Theranostics, 8(20), 5660-5661. https://doi.org/10.7150/thno.31152.

ACS
Hu, K.; Yin, F.; Yu, M.; Sun, C.; Li, J.; Liang, Y.; Li, W.; Xie, M.; Lao, Y.; Liang, W.; Li, Z.g. In-Tether Chiral Center Induced Helical Peptide Modulators Target p53-MDM2/MDMX and Inhibit Tumor Growth in Stem-Like Cancer Cell: Erratum. Theranostics 2018, 8 (20), 5660-5661. DOI: 10.7150/thno.31152.

NLM
Hu K, Yin F, Yu M, Sun C, Li J, Liang Y, Li W, Xie M, Lao Y, Liang W, Li Zg. In-Tether Chiral Center Induced Helical Peptide Modulators Target p53-MDM2/MDMX and Inhibit Tumor Growth in Stem-Like Cancer Cell: Erratum. Theranostics 2018; 8(20):5660-5661. doi:10.7150/thno.31152. https://www.thno.org/v08p5660.htm

CSE
Hu K, Yin F, Yu M, Sun C, Li J, Liang Y, Li W, Xie M, Lao Y, Liang W, Li Zg. 2018. In-Tether Chiral Center Induced Helical Peptide Modulators Target p53-MDM2/MDMX and Inhibit Tumor Growth in Stem-Like Cancer Cell: Erratum. Theranostics. 8(20):5660-5661.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image

©2024 Ivyspring International Publisher. Terms of use